June 9 (Reuters) - Vertex Pharmaceuticals Inc (VRTX.O), opens new tab said the U.S. Food and Drug Administration has approved the expanded use of its Trikafta cocktail therapy to treat cystic fibrosis ...
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs), today announced a global, multi-target license and option agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback